In this double-blind , randomised , dose-ranging phase 2b study , men and women ( aged 16 years ) with microscopically confirmed P vivax monoinfection ( parasite density > 100 to < 100,000 per L blood ) were enrolled from community health centres and hospitals across seven sites in Brazil , Peru , India , and Thailand .